Loading clinical trials...
Loading clinical trials...
This study looks at overall impact of the use of DuraTouch® in terms of ease, convenience to use and satisfaction in participants with either type 1 or type 2 diabetes.The study will last for about 12...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT07590193 · Diabetes Mellitus, Type 2
NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more
NCT02861781 · Obesity, Insulin Resistance, and more
NCT05692388 · Diabetic Nephropathy Type 2 - Uncontrolled, Diabetes Mellitus, Type 2, and more
NCT07222137 · Diabetes Mellitus, Type 1
Ginemedica Sp. z o.o. Sp.k
Wroclaw, Kuyavian-Pomeranian Voivodeship
CenterMed Krakow Sp. z o.o.
Krakow, Lesser Poland Voivodeship
Diabetolog praktyka lekarska - Bartosz Bednarkiewicz
Lubin, Lower Silesian Voivodeship
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions